JBC Advanced Peptides, Inc.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M503640200 on June 9, 2005

J. Biol. Chem., Vol. 280, Issue 31, 28572-28580, August 5, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
280/31/28572    most recent
M503640200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bundschu, K.
Right arrow Articles by Schuh, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bundschu, K.
Right arrow Articles by Schuh, K.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Gene Disruption of Spred-2 Causes Dwarfism*

Karin Bundschu{ddagger}§, Klaus-Peter Knobeloch¶, Melanie Ullrich{ddagger}, Thorsten Schinke||, Michael Amling||, Catherine M. Engelhardt{ddagger}, Thomas Renné{ddagger}, Ulrich Walter{ddagger}, and Kai Schuh{ddagger}**

From the {ddagger}Institut für Klinische Biochemie und Pathobiochemie, Josef-Schneider-Strasse 2, 97080 Würzburg, Germany, the §Universitäts-Frauenklinik, Josef-Schneider-Strasse 4, 97080 Würzburg, Germany, the Forschungsinstitut für Molekulare Pharmakologie, Krahmerstrasse 6, 12207 Berlin, Germany, and the ||Experimentelle Unfallchirurgie, Martinistrasse 52, 20246 Hamburg, Germany

The impact of the fibroblast growth factor receptor 3 (FGFR3)-mediated signaling pathway on bone growth has been demonstrated by various genetic approaches. Overexpression of fibroblast growth factors (FGFs), several gain-of-function mutations in the FGFR3, and constitutive activation of mitogen-activated protein kinase (MAPK) kinase (MEK1) in chondrocytes have been shown to cause dwarfism in mice by activation of the MAPK signaling pathway. To investigate the previously reported inhibitory role of Spred in the FGFR3/MAPK pathway, we generated mice with a trapped Spred-2 gene. Here we show that lack of functional Spred-2 protein in mice caused a dwarf phenotype, similar to achondroplasia, the most common form of human dwarfism. Spred-2-/- mice showed reduced growth and body weight, they had a shorter tibia length, and showed narrower growth plates as compared with wild-type mice. We detected promoter activity and protein expression of Spred-2 in chondrocytes, suggesting an important function of Spred-2 in chondrocytes and bone development. Stimulation of chondrocytes with different FGF concentrations showed earlier and augmented ERK phosphorylation in Spred-2-/- chondrocytes in comparison to Spred-2+/+ chondrocytes. Our observations suggest a model in which loss of Spred-2 inhibits bone growth by inhibiting chondrocyte differentiation through up-regulation of the MAPK signaling pathway.


Received for publication, April 4, 2005 , and in revised form, June 9, 2005.

* This work was supported by grants of the Interdisziplinäres Zentrum für Klinische Forschung Wuerzburg (to K. B.), the German Research Foundation (Deutsche Forschungsgemeinschaft), Novartis-Foundation, Germany, and the Deutsche Vereinigte Gesellschaft für Klinische Chemie und Laboratoriumsmedizin "DGKL Scherer-Stipendium" (to K. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

** To whom correspondence should be addressed: Institut für Klinische Biochemie und Pathobiochemie, Josef-Schneider-Strasse 2, 97080 Würzburg, Germany. Tel.: 49-931-201-36116; Fax: 49-931-201-45137; E-mail: kai.schuh{at}klin-biochem.uni-wuerzburg.de.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Mol. Biol. CellHome page
C. Johne, D. Matenia, X.-y. Li, T. Timm, K. Balusamy, and E.-M. Mandelkow
Spred1 and TESK1--Two New Interaction Partners of the Kinase MARKK/TAO1 That Link the Microtubule and Actin Cytoskeleton
Mol. Biol. Cell, April 1, 2008; 19(4): 1391 - 1403.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
C. Li, D. A. Scott, E. Hatch, X. Tian, and S. L. Mansour
Dusp6 (Mkp3) is a negative feedback regulator of FGF-stimulated ERK signaling during mouse development
Development, January 1, 2007; 134(1): 167 - 176.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Bundschu, U. Walter, and K. Schuh
The VASP-Spred-Sprouty Domain Puzzle
J. Biol. Chem., December 1, 2006; 281(48): 36477 - 36481.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.